Insider Trading History of Keane Raymond T

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Keane Raymond T since 2010. The trader's CIK number is 1448434. At the time of the last reporting, Keane Raymond T was the SVP General Counsel & CCO of Ariad Pharmaceuticals Inc. (stock ticker symbol ARIA). Also see all insider trading activities at Ariad Pharmaceuticals Inc.


Yearly summary of insider trading at Ariad Pharmaceuticals Inc (ARIA) by Keane Raymond T

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ARIA 0 $0 26,084 $498,821 52,166 $0
2012 ARIA 0 $0 81,280 $1,464,431 102,750 $87,950
2011 ARIA 0 $0 0 $0 26,334 $0
2010 ARIA 0 $0 10,256 $41,947 0 $0


Insider trading of Ariad Pharmaceuticals Inc (ARIA) by Keane Raymond T

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-07-18 ARIA Sale 8,000 19.79 158,288
2013-07-15 ARIA Option Ex 16,000 .00 0
2013-04-01 ARIA Option Ex 5,166 .00 0
2013-04-02 ARIA Sale 2,583 18.05 46,625
2013-03-22 ARIA Option Ex 26,333 .00 0
2013-03-25 ARIA Sale 13,167 18.87 248,487
2013-03-20 ARIA Option Ex 4,667 .00 0
2013-03-22 ARIA Sale 2,334 19.46 45,421
2012-12-18 ARIA Option Ex 7,750 .00 0
2012-09-06 ARIA Sale 10,000 22.00 220,000
2012-09-06 ARIA Option Ex 10,000 2.39 23,900
2012-09-04 ARIA Sale 7,780 21.00 163,380
2012-08-15 ARIA Option Ex 10,000 2.39 23,900
2012-08-15 ARIA Sale 10,000 20.00 200,000
2012-07-30 ARIA Sale 10,000 19.00 190,000
2012-07-26 ARIA Sale 10,000 18.00 180,000
2012-07-26 ARIA Option Ex 10,000 2.39 23,900
2012-04-01 ARIA Option Ex 5,167 .00 0
2012-04-03 ARIA Sale 2,067 16.18 33,454
2012-03-23 ARIA Sale 10,533 15.41 162,271
2012-03-22 ARIA Option Ex 26,333 .00 0
2012-03-19 ARIA Option Ex 21,000 .00 0
2012-03-20 ARIA Sale 8,400 15.02 126,151
2012-02-14 ARIA Option Ex 12,500 1.30 16,250
2012-02-14 ARIA Sale 12,500 15.13 189,175
2011-03-22 ARIA Option Ex 26,334 .00 0
2010-05-17 ARIA Sale 10,256 4.09 41,947

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keane Raymond T (SVP General Counsel & CCO of Ariad Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.